BIOCRYST PHARMACEUTICALS, INC. Trademark

Trademark Overview

On Tuesday, June 11, 2002, a trademark application was filed for BIOCRYST PHARMACEUTICALS, INC. with the United States Patent and Trademark Office. The USPTO has given the BIOCRYST PHARMACEUTICALS, INC. trademark a serial number of 76420562. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, May 23, 2015. This trademark is owned by BioCryst Pharmaceuticals, Inc.. The BIOCRYST PHARMACEUTICALS, INC. trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of viral, inflammatory, autoimmune, cancer [ and cardiovascular ] disease and disorders
biocryst pharmaceuticals, inc.

General Information

Serial Number76420562
Word MarkBIOCRYST PHARMACEUTICALS, INC.
Filing DateTuesday, June 11, 2002
Status800 - REGISTERED AND RENEWED
Status DateSaturday, May 23, 2015
Registration Number2902002
Registration DateTuesday, November 9, 2004
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 17, 2003

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of viral, inflammatory, autoimmune, cancer [ and cardiovascular ] disease and disorders
Pseudo MarkBIOCRYST PHARMACEUTICALS INCORPORATED
Disclaimer with Predetermined Text"PHARMACEUTICALS, INC."

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 22, 2002
Primary Code005
First Use Anywhere DateThursday, December 12, 1991
First Use In Commerce DateThursday, November 19, 1992

Trademark Owner History

Party NameBioCryst Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703
Party NameBioCryst Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBirmingham, AL 35244
Party NameBioCryst Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBirmingham, AL 35244

Trademark Events

Event DateEvent Description
Thursday, November 9, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, May 3, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, July 21, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 21, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 21, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 6, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 6, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 6, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 16, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 16, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, July 12, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, May 24, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, May 23, 2015REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, May 23, 2015REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, May 23, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, May 7, 2015TEAS SECTION 8 & 9 RECEIVED
Friday, June 3, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, June 3, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, May 5, 2011TEAS SECTION 8 & 15 RECEIVED
Friday, September 21, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 21, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 9, 2004REGISTERED-PRINCIPAL REGISTER
Thursday, September 16, 2004LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, August 30, 2004ASSIGNED TO LIE
Wednesday, August 25, 2004ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 28, 2004ASSIGNED TO EXAMINER
Monday, June 28, 2004STATEMENT OF USE PROCESSING COMPLETE
Monday, June 28, 2004USE AMENDMENT FILED
Tuesday, July 6, 2004CASE FILE IN TICRS
Monday, June 28, 2004TEAS STATEMENT OF USE RECEIVED
Wednesday, March 3, 2004SOU EXTENSION 1 GRANTED
Wednesday, March 3, 2004SOU EXTENSION 1 FILED
Wednesday, March 3, 2004SOU TEAS EXTENSION RECEIVED
Tuesday, September 9, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 17, 2003PUBLISHED FOR OPPOSITION
Wednesday, May 28, 2003NOTICE OF PUBLICATION
Tuesday, April 22, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 21, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 24, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 24, 2003PAPER RECEIVED
Wednesday, March 19, 2003TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 3, 2002NON-FINAL ACTION MAILED
Thursday, September 19, 2002ASSIGNED TO EXAMINER

Related Keywords

pharmaceuticals biocryst cardiovascular disease disorders cancer autoimmune treatment viral inflammatory